IMPLEMENTATION LEVEL

National

AFFECTED FLOW

Outflow (subsidised)

ANNOUNCED AS TEMPORARY

No

NON-TRADE-RELATED RATIONALE

No

ELIGIBLE FIRMS

firm-specific

JUMBO

No

TARIFF PEAK

No
← back to the state act
Inception date: 01 Feb 2017 | Removal date: open ended
Still in force

Other export incentive

On 1 February 2017, the Drug Regulatory Authority of Pakistan issued a Circular incentivizing Pharmaceutical firms and manufacturers with high export performance. The incentive is in the form of prioritizing registration of molecules, provided these drugs meet all prescribed requirements. One molecule will be granted priority for every USD 100,000 export of medicines during the year, subject to a maximum of 5 molecules per year.

AFFECTED COUNTRIES

MAP
TABLE
EXPORT

AFFECTED SECTORS AND PRODUCTS

352 Pharmaceutical products

Please report this page in case you detect an inaccuracy in its content.